xPedite: A Study to Expedite DIPG and DMG Research

Part of paid clinical trials in Los Altos, California.

Sponsor
xCures
Study ID
NCT06140719
Status
Recruiting
Apply to this trial

Conditions

  • DIPG
  • DMG
  • Oncology

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This study will gather data from new and existing patients with patient medical records, and patient/family/caregiver reported information to establish a clear natural history of disease suitable to serve as an external, contemporary or historical control arm for future therapeutic development programs of drugs, devices, or biologic interventions in DMG or DIPG.

Key Dates

Start date
Nov 1, 2023
Status verified
Apr 2024
Primary completion
Sep 30, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
400 participants (estimated)

Primary Outcome Measure

Overall Survival (OS) [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
xCures, Inc.Los AltosCalifornia94022
Bryan Federowicz

Find similar trials in Los Altos, CA

By research site
xCures, Inc.· Los Altos, CA

Related Studies